PMC9998245_01
Course of treatment and general condition of the patient. SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TAZ/PIPC, tazobactam/piperacillin; LVFX, levofloxacin; VCZ, voriconazole; FLCZ, fluconazole; DEX, dexamethasone; FiO2, fraction of inspiratory oxygen; RCC, red cell concentrate; PCR, polymerase chain reaction, IVIG, intravenous immunoglobulin; NC, nasal cannula; NHF, nasal high flow; Hb, hemoglobin; CT value, cycle threshold value.
prm-8-20230007-g001.jpg
PMC9998245_01_prm-8-20230007-g001.jpg
fig_001
The course of treatment and general condition during hospitalization are shown in Fig. 1 On admission, the patient had a fever and respiratory failure. The course of physical therapy is shown in Fig. 1 Therapy began on day 6 of hospitalization and was conducted in the patient's private isolation room by therapists wearing personal protective equipment (Fig. 2). The progress of physical therapy is shown in Fig. 1.